Lightintegra Technology: Blood diag dev LightIntegra Tech raises $4m

Medical device developer LightIntegra Technology said last Friday it raised $3.5 million in financing from its existing shareholder base to support its blood diagnostic tech development. The Vancouver-based company is developing diagnostics looking to reduce blood transfusions in cancer patients and minimize platelet refractoriness. LightIntegra's flagship device is the ThromboLUX, which identifies non-activated platelet products [...]The post Blood diag dev LightIntegra Tech raises $4m appeared first on MassDevice.